MS Speaks

The Multiple Sclerosis Journal sometimes gives the pro and con arguments on a controversial topic, followed by a commentary summing up the two discussions. On June 1 the topic was whether gadolinium should always be used to assess disease activity in MS. The link below gives the first part of the argument against gadolinium:



https://journals.sagepub.com/doi/abs/10.1177/1352458520914819